First reported 17 hours ago -
Updated 11 hours ago -
Prof John Crown: said a patient battling malignant melanoma had been deemed appropriate for the drug, Ipilimumab, but the insurance company, GloHealth, had informed him that it would not cover its members for the treatment. Some cancer patients with private ...
[Published Irish Times - 11 hours ago]